Quick Answer
Altimmune, Inc. reported Total Revenue of $41.0 thousand for fiscal year 2025.
Altimmune, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $41.0K | +105.0% |
| 2024 | $20.0K | -95.3% |
| 2023 | $426.0K | +726.5% |
| 2022 | -$68.0K | -101.5% |
| 2021 | $4.41M | -46.1% |
| 2020 | $8.19M | +41.1% |
| 2019 | $5.80M | -43.8% |
| 2018 | $10.33M | -3.8% |
| 2017 | $10.74M | +231.8% |
| 2016 | $3.24M | -86.7% |
| 2011 | $24.27M | +15.6% |
| 2010 | $20.99M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.0K | +0.0% | +0.0% |
| June 30, 2025 | $5.0K | +0.0% | +0.0% |
| March 31, 2025 | $5.0K | +0.0% | +0.0% |
| September 30, 2024 | $5.0K | -98.6% | +0.0% |
| June 30, 2024 | $5.0K | -16.7% | +0.0% |
| March 31, 2024 | $5.0K | -76.2% | -98.6% |
| September 30, 2023 | $362.0K | +18000.0% | +5933.3% |
| June 30, 2023 | $6.0K | -25.0% | -71.4% |
- Altimmune, Inc. showed an increase of +105.0% in Total Revenue compared to the prior fiscal year.
- Over the 2010–2025 period, Altimmune, Inc.’s total revenue has declined by 99.8% (from $20.99 million to $41.0 thousand).
- The most recent figure is from Altimmune, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: